Does USTEKINUMAB Cause Treatment failure? 3,248 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,248 reports of Treatment failure have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 3.8% of all adverse event reports for USTEKINUMAB.
3,248
Reports of Treatment failure with USTEKINUMAB
3.8%
of all USTEKINUMAB reports
884
Deaths
1,328
Hospitalizations
How Dangerous Is Treatment failure From USTEKINUMAB?
Of the 3,248 reports, 884 (27.2%) resulted in death, 1,328 (40.9%) required hospitalization, and 1,161 (35.7%) were considered life-threatening.
Is Treatment failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 3,248 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Treatment failure?
METHOTREXATE (14,672)
ETANERCEPT (11,893)
ADALIMUMAB (9,990)
ABATACEPT (9,301)
RITUXIMAB (9,217)
TOCILIZUMAB (9,097)
HYDROXYCHLOROQUINE (8,786)
LEFLUNOMIDE (8,686)
INFLIXIMAB (8,535)
SULFASALAZINE (7,423)
Which USTEKINUMAB Alternatives Have Lower Treatment failure Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE